Genetic Variations and mRNA Expression of NRF2 in Parkinson’s Disease
Nuclear factor erythroid 2-like 2 (NRF2) encodes a transcription factor regulating mechanisms of cellular protection and is activated by oxidative stress. NRF2 has therefore been hypothesized to confer protection against Parkinson’s disease and so far an NRF2 haplotype has been reported to decrease...
Saved in:
Main Authors: | Caroline Ran, Karin Wirdefeldt, Lovisa Brodin, Mehrafarin Ramezani, Marie Westerlund, Fengqing Xiang, Anna Anvret, Thomas Willows, Olof Sydow, Anders Johansson, Dagmar Galter, Per Svenningsson, Andrea Carmine Belin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2017/4020198 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possible Involvement of a Mitochondrial Translation Initiation Factor 3 Variant Causing Decreased mRNA Levels in Parkinson's Disease
by: Anna Anvret, et al.
Published: (2010-01-01) -
Sex Differences in the Allele Distribution of PGLYRP2 Variant rs892145 in Parkinson’s Disease
by: Caroline Ran, et al.
Published: (2023-01-01) -
Feasibility Aspects of Exploring Exercise-Induced Neuroplasticity in Parkinson’s Disease: A Pilot Randomized Controlled Trial
by: Hanna Johansson, et al.
Published: (2020-01-01) -
Myocarditis following mRNA COVID‐19 vaccination: call for endomyocardial biopsy
by: Daniel Kiblboeck, et al.
Published: (2022-06-01) -
The Beneficial Role of Nrf2 in the Endothelial Dysfunction of Atherosclerosis
by: Zixia Huang, et al.
Published: (2022-01-01)